C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 241/36 (2006.01) A61K 31/695 (2006.01) C07C 271/20 (2006.01) C07C 271/30 (2006.01) C07C 311/40 (2006.01) C07C 311/42 (2006.01) C07D 231/10 (2006.01) C07D 307/02 (2006.01) C07D 309/06 (2006.01) C07F 7/10 (2006.01)
Patent
CA 2533638
Compounds, pharmaceutical compositions and methods are provided that are useful in the treatment or prevention of lipid disorders, metabolic disorders and cell-proliferative diseases. In particular, the invention provides compounds which modulate the expression and/or function of proteins involved in cholesterol metabolism. The subject compounds are particularly useful in the treatment of obesity, diabetes, hypercholesterolemia, atherosclerosis and hypolipoproteinemia.
L'invention concerne des composés, des compositions pharmaceutiques et des procédés servant à traiter ou prévenir des troubles lipidiques, des troubles métaboliques ainsi que des maladies liées à la prolifération cellulaire. Cette invention se rapporte en particulier à des composés qui modulent l'expression et/ou le fonctionnement de protéines impliquées dans le métabolisme du cholestérol. Les composés selon l'invention servent en particulier à traiter l'obésité, le diabète, l'hypercholestérolémie, l'athérosclérose et l'hypolipoproteinémie.
Harrison Martin J.
Jiao Xianyun
Jones Stuart D.
Kayser Frank
Kopecky David J.
Amgen Inc.
Gowling Lafleur Henderson Llp
LandOfFree
Arylsulfonamidobenzylic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Arylsulfonamidobenzylic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Arylsulfonamidobenzylic compounds will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1616923